Results 131 to 140 of about 97,443 (231)
Transient inhibition of MEK/ERK and WNT pathways enhances direct differentiation of primed hPSCs into functional trophoblast stem cells. [PDF]
Jiang Q, Liu P, Chen C.
europepmc +1 more source
ABSTRACT Background Caesarean scar ectopic pregnancy (CSEP) is defined by the implantation and development of a gestational sac inside a caesarean scar defect, but variations in classification systems and diagnostic criteria exist. Objectives This study aimed to systematically review the different criteria used in the medical literature to diagnose ...
Simrit Nijjar +5 more
wiley +1 more source
Something Old, Something New, Something Borrowed… About the Placenta. [PDF]
Milova N +4 more
europepmc +1 more source
ABSTRACT Background Delayed villous maturation (DVM) is a placental maturation disorder that mainly affects maternal‐to‐foetal oxygen transfer. Objectives We conducted a systematic review, meta‐analysis, and sensitivity analysis exploring study heterogeneities (I2) of risk factors and outcomes associated with histopathological findings of DVM.
Muhammad Pradhiki Mahindra +6 more
wiley +1 more source
Caffeine Exposure Modulates Trophoblast Differentiation and Estradiol Synthesis. [PDF]
Keum J, Lee J, Ryu KY, Roh J.
europepmc +1 more source
PPAR /RXR Heterodimers Are Involved in Human CG Synthesis and Human Trophoblast Differentiation
Anne Couturier‐Tarrade
openalex +2 more sources
ABSTRACT Aim Reduced placental mTOR signaling is associated with intrauterine growth restriction and impaired maternal and placental metabolism. Since maternal hypothyroidism induces intrauterine growth restriction, and maternal treatment with kisspeptin‐10 (Kp10) has been shown to improve feto‐placental development in hypothyroid rats, this study ...
Bianca Reis Santos +9 more
wiley +1 more source
In Vitro 3D Model of Human Endometrial Stromal and Trophoblast Cells: Techniques for an Optimized Formation and Cryopreservation of Spheroids. [PDF]
Muthuraj K +5 more
europepmc +1 more source
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke +30 more
wiley +1 more source
Modeling human placental biology: a review of organoid technologies. [PDF]
Bashi A, Joseph T, Schuch V, Johnson EL.
europepmc +1 more source

